The last 10 days of patients with glioblastoma: Assessment of clini- cal signs and symptoms as well as treatment. Am J Hosp Palliat Care. 2016;33:985--8.Their, K.; Calabek, B.; Tinchon, A.; Grisold, W.; Oberndorfer, S. The last 10 days of patients with glioblas- toma: ...
Left, glioma cells were treated with different concentrations of T-96 for 2 days; right, cells were treated with 10 μM T-96 for different times. Survival was evaluated using MTT assays, and the data are presented as the means ± SD, n = 3). b Images of LN-229 and U-...
Blood 113(14): 3161 – 3167 Stratmann A, Risau W, Plate KH (1998) Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 153(5): 1459 – 1466 Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, ...
The last 10 days of patients with glioblastoma: Assessment of clini- cal signs and symptoms as well as treatment. Am J Hosp Palliat Care. 2016;33:985--8.Their, K.; Calabek, B.; Tinchon, A.; Grisold, W.; Oberndorfer, S. The last 10 days of patients with glioblas- toma: ...
MINA controls proliferation and tumorigenesis of glioblastoma by epigenetically regulating cyclins and CDKs via H3K9me3 demethylation. Oncogene 2017; 36: 387–396. 61. Yang R, Yi L, Dong Z, Ouyang Q, Zhou J, Pang Y et al. Tigecycline inhibits glioma growth by regulating miRNA-199b-5p-HES1...